Who owns ONCOLOGY INSTITU?
- Ticker: TOI
- CUSIP Number: 68236x100
Tip: Access positions for across all investors
Analyze quarterly positions in Oncology Institu with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Oncology Institu stock
Who bought or sold ONCOLOGY INSTITU this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 4.8M | $7.5M | 0% | Mar 2024 |
|
| Deerfield Management Company | 3.4M | $5.3M | 0% | Mar 2024 |
|
| Vanguard Group | 1.8M | $2.8M | 0% | Mar 2024 |
|
| Balyasny Asset Management | 1.7M | $2.7M | 38% | Mar 2024 |
|
| Kent Lake Capital | 1.2M | $1.9M | 9% | Mar 2024 |
|
| Triatomic Management | 885k | $1.4M | -2% | Mar 2024 |
|
| Cincinnati Insurance Company | 700k | $1.1M | 0% | Mar 2024 |
|
| TIFF Advisory Services | 423k | $669k | 0% | Mar 2024 |
|
| Geode Capital Management | 354k | $560k | 16% | Mar 2024 |
|
| FourWorld Capital Management | 250k | $396k | 100% | Mar 2024 |
|
| BlackRock | 149k | $236k | -37% | Mar 2024 |
|
| Millennium Management | 148k | $234k | -15% | Mar 2024 |
|
| Squarepoint Ops | 106k | $167k | 9% | Mar 2024 |
|
| Saba Capital Management | 94k | $149k | 0% | Mar 2024 |
|
| Morgan Stanley | 71k | $141k | 1192% | Mar 2024 |
|
| Fielder Capital Group | 70k | $111k | 0% | Mar 2024 |
|
| Northern Trust | 65k | $103k | 46% | Mar 2024 |
|
| Quattro Financial Advisors | 56k | $88k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 45k | $71k | -7% | Mar 2024 |
|
| Acadian Asset Management | 39k | $60k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 31k | $49k | 46% | Mar 2024 |
|
| Citadel Advisors | 30k | $48k | -79% | Mar 2024 |
|
| HighTower Advisors | 28k | $44k | 100% | Mar 2024 |
|
| Nwam | 28k | $25k | 100% | Mar 2024 |
|
| XTX Topco | 28k | $44k | -40% | Mar 2024 |
|
| Emerald Investment Partners | 24k | $38k | 0% | Mar 2024 |
|
| Diametric Capital | 22k | $35k | -86% | Mar 2024 |
|
| JustInvest | 19k | $30k | -8% | Mar 2024 |
|
| Brown Advisory Holdings Incorporated | 19k | $30k | 0% | Mar 2024 |
|
| Mariner Wealth Advisors | 18k | $29k | 0% | Mar 2024 |
|
| Citigroup | 13k | $20k | 2481% | Mar 2024 |
|
| UBS Group | 10k | $16k | 100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 9.4k | $15k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 8.8k | $14k | 7205% | Mar 2024 |
|
| Tower Research Capital | 7.8k | $12k | 100% | Mar 2024 |
|
| Boston Financial Mangement | 7.4k | $652k | 100% | Mar 2024 |
|
| Bank of America Corporation | 3.9k | $6.2k | -88% | Mar 2024 |
|
| Kirr Marbach & Co | 2.7k | $331k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 2.2k | $3.4k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 248.00 | $391.988800 | 2% | Mar 2024 |
|
| Royal Bank of Canada | 55.00 | $0 | -95% | Mar 2024 |
|
Who sold out of Oncology Institu?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Josh Arnold Investment Consultant | Dec 2023 | 1.9M | $3.8M |
| Alyeska Investment Group | Dec 2023 | 84k | $171k |
| Springbok Capital Management | Sep 2023 | 50k | $70k |
| Marshall Wace | Dec 2023 | 39k | $80k |
| Jane Street | Dec 2023 | 28k | $58k |
| Virtu Financial | Sep 2023 | 14k | $20k |
| Cubist Systematic Strategies | Dec 2023 | 12k | $25k |